Search - tctmd.com

Displaying 21 - 40 of 44

Sort: Relevancy | Date

News Conference News EuroPCR 2018

Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions

Michael O'Riordan

May 23, 2018

News Conference News EuroPCR 2018

FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data

Caitlin E. Cox

May 22, 2018

News Conference News EuroPCR 2018

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

Shelley Wood

May 22, 2018

News Conference News EuroPCR 2018

FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis

Michael O'Riordan

May 22, 2018

News Features

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Michael O'Riordan

November 27, 2017

News Conference News TCT 2017

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

L.A. McKeown

November 02, 2017

News Conference News EuroPCR 2017

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

Shelley Wood

May 12, 2017

News Conference News ACC 2017

CMR Perfusion Imaging Holds Its Own Against Invasive Approach to Managing Stable Angina

Todd Neale

March 22, 2017

News Conference News ACC 2017

To Stent or Not to Stent? iFR vs FFR Late Breakers at ACC 2017 Seek to Shake Up Treatment Decisions

Caitlin E. Cox

March 14, 2017

News Daily News

Registry Hints Staged Intervention Reduces Mortality in STEMI Patients With Multivessel CAD, but Controversy Remains

L.A. McKeown

January 09, 2017

News Conference News AHA 2016

Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study

Michael O'Riordan

November 14, 2016

News Conference News ESC 2015

PLATFORM: More Than 60% of Planned Catheterizations Cancelled When CT-Derived FFR Guides Care

L.A. McKeown

September 02, 2015

News Conference News ACC 2015

DANAMI3-PRIMULTI: Complete Revascularization Improves Outcomes for STEMI

Yael L. Maxwell

March 17, 2015

News Daily News

Meta-analysis Confirms Benefits of FFR-Guided Revascularization

Yael L. Maxwell

October 24, 2014

News Conference News ESC 2014

FAME 2: FFR-Guided PCI Continues on Same Trajectory from 1 to 2 Years

Caitlin E. Cox

September 02, 2014

News Conference News ESC 2014

FAMOUS-NSTEMI: FFR Guidance Reduces Revascularization in NSTEMI

Todd Neale

September 01, 2014

News Daily News

SCAI Paper Outlines ‘Best Practices’ for FFR, IVUS, OCT

Yael L. Maxwell

November 14, 2013

News Conference News TCT 2013

Novel Ischemia Measurement Strategies Show Potential vs. FFR

October 30, 2013

News Daily News

FAME 2: FFR-Guided PCI ‘Economically Attractive’ vs. Medical Therapy Alone

Caitlin E. Cox

August 30, 2013

News Daily News

Study Seeks to CLARIFY Accuracy of Adenosine-Free Pressure Index vs. FFR

March 28, 2013

Advertisement

Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions

FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

CMR Perfusion Imaging Holds Its Own Against Invasive Approach to Managing Stable Angina

To Stent or Not to Stent? iFR vs FFR Late Breakers at ACC 2017 Seek to Shake Up Treatment Decisions

Registry Hints Staged Intervention Reduces Mortality in STEMI Patients With Multivessel CAD, but Controversy Remains

Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study

PLATFORM: More Than 60% of Planned Catheterizations Cancelled When CT-Derived FFR Guides Care

DANAMI3-PRIMULTI: Complete Revascularization Improves Outcomes for STEMI

Meta-analysis Confirms Benefits of FFR-Guided Revascularization

FAME 2: FFR-Guided PCI Continues on Same Trajectory from 1 to 2 Years

FAMOUS-NSTEMI: FFR Guidance Reduces Revascularization in NSTEMI

SCAI Paper Outlines ‘Best Practices’ for FFR, IVUS, OCT

Novel Ischemia Measurement Strategies Show Potential vs. FFR

FAME 2: FFR-Guided PCI ‘Economically Attractive’ vs. Medical Therapy Alone

Study Seeks to CLARIFY Accuracy of Adenosine-Free Pressure Index vs. FFR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content